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Summary
Campomelic dysplasia (CD), a skeletal malformation
syndrome with or without XY sex reversal, is usually
caused by mutations within the SOX9 gene on distal
17q. Several CD translocation and inversion cases have
been described with breakpoints outside the coding re-
gion, mapping to locations 1130 kb proximal to SOX9.
Such cases are generally less severely affected than cases
with SOX9 coding-region mutations, as is borne out by
three new translocation cases that we present. We have
cloned the region extending 1.2 Mb upstream of the
SOX9 gene in overlapping bacterial-artificial-chromo-
some and P1-artificial-chromosome clones and have es-
tablished a restriction map with rare-cutter enzymes.
With sequence-tagged-site–content mapping in somatic-
cell hybrids, as well as with FISH, we have precisely
mapped the breakpoints of the three new and of three
previously described CD cases. The six CD breakpoints
map to an interval that is 140–950 kb proximal to the
SOX9 gene. With exon trapping, we could isolate five
potential exons from the YAC 946E12 that spans the
region, four of which could be placed in the contig in
the vicinity of the breakpoints. They show the same
transcriptional orientation, but only two have an open
reading frame (ORF). We failed to detect expression of
these fragments in several human and mouse cDNA li-
braries, as well as on northern blots. Genomic sequence
totaling 1,063 kb from the SOX9 5′-flanking region was
determined and was analyzed by the gene-prediction
program GENSCAN and by a search of dbEST and
other databases. No genes or transcripts could be iden-
tified. Together, these data suggest that the chromosomal
rearrangements most likely remove one or more cis-reg-
ulatory elements from an extended SOX9 control region.
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Introduction
Campomelic dysplasia (CD [MIM 114290]) is a rare
autosomal dominant syndrome characterized by skeletal
anomalies including bowed femora and tibiae, hypo-
plastic scapulae, 11 pairs of ribs, pelvic malformations,
and clubbed feet. Malformations such as micrognathia,
retroglossia, cleft palate, narrow airways caused by
tracheobronchial cartilage defects, hypoplastic lungs,
and a bell-shaped thorax are usually present and are the
major cause of the severe respiratory problems that arise
soon after birth, leading to death mostly during the ne-
onatal period (Houston et al. 1983; Mansour et al.
1995). Male-to-female sex reversal of variable degree is
present in approximately two-thirds of the XY cases
(Houston et al. 1983; Mansour et al. 1995).
De novo chromosomal rearrangements involving dis-
tal 17q in several patients with CD (Maraia et al. 1991;
Young et al. 1992; Tommerup et al. 1993) first allowed
assignment of the CD/sex reversal locus to 17q24.3-
q25.1 (Tommerup et al. 1993) and subsequently led to
the identification of the SOX9 gene in the vicinity of
CD translocation breakpoints (Foster et al. 1994; Wag-
ner et al. 1994). De novo heterozygous loss-of-function
mutations in SOX9 in cytologically normal patientswith
CD who have XY sex reversal identified haploinsuffi-
ciency for SOX9 as the cause of both phenotypes (Foster
et al. 1994;Wagner et al. 1994).More than 25mutations
in SOX9 that result in CD have been described so far,
but no genotype/phenotype correlation is apparent (Fos-
ter et al. 1994; Wagner et al. 1994; Kwok et al. 1995;
Cameron et al. 1996; Meyer et al. 1997; Goji et al. 1998;
Hageman et al. 1998), indicating variable expressivity
of both disease severity and the presence of XY sex re-
versal. Consistent with defects in skeletal and gonadal
development seen in patients with CD, expression of the
mouse Sox9 gene has been documented at sites of en-
suing cartilage deposition throughout embryogenesis
(Wright et al. 1995; Ng et al. 1997) and in the developing
testis (Kent et al. 1996; Morais da Silva et al. 1996).
Both in vitro and in vivo studies have identified the
Col2a1 collagen gene as a target for SOX9 during chon-
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Table 1
Clinical Symptoms and Radiological Findings in Three New CD Translocation Cases
STATUS INa
Case 8, t(10;17) Case 9, t(5;17) Case 11, t(17;22)
Clinical symptoms:
Macrocephaly   
High forehead   
Epicanthic folds   
Flat nasal bridge   
Low-set ears  ND 
Cleft palate   
Micrognathia   
Respiratory distress   
Congenital dislocation of hips ND ND 
Bowed femora   
Bowed tibiae ()  
Pretibial skin dimples   ND
Clubfeet   
Genitalia Male, hypospadias Normal female Male, small penis
Radiological findings:
Hypoplastic scapulae   
Small chest   Bell shaped
11 Ribs   
Nonmineralized thoracic pedicles  ND 
Kyphosis or scoliosis   
Vertically narrow iliac bones   
Abnormal ischial bones   ND
Poorly developed pubic bones  ND 
Bowed femora   
Bowed tibiae   ND
Hypoplastic fibulae   ND
Bowed humeri ND  
Bowed radii or ulnae ND  
Short first metacarpal ND ND 
a Case numbers are as in table 2. A plus sign () denotes presence of the symptom (the parentheses around the plus
sign for “bowed tibiae” denotes that the bowing was mild), and a minus sign () denotes absence of the symptom; ND
 not described.
drogenesis (Bell et al. 1997; Lefebvre et al. 1997; Ng et
al. 1997). Recently, evidence for the involvement of
SOX9 in the expression of the AMH gene, an early
marker of Sertoli-cell differentiation, has been presented
(de Santa Barbara et al. 1998).
SOX9 is a member of the growing SOX-gene family,
which is related by homology to the HMG-box region
of the testis-determining gene SRY (“SOX” is an acro-
nym for “SRY-related HMG-box”) (Sinclair et al. 1990;
Pevny and Lovell-Badge 1997). The HMG box encodes
a DNA-binding domain encompassing 80 amino acids
that is present in a large number of transcription factors
(Grosschedl et al. 1994). In addition to its HMG do-
main, which has been shown to recognize typical SOX
binding sequences (Lefebvre et al. 1997; Meyer et al.
1997; Ng et al. 1997), SOX9 has a second domain es-
sential for its function, a C-terminal transcription-acti-
vation domain (Su¨dbeck et al. 1996).
Until now, 11 CD cases have been described in which
a chromosomal rearrangement seems to cause the disease
(Maraia et al. 1991; Young et al. 1992; Tommerup et
al. 1993; Mansour et al. 1995; Ninomiya et al. 1995;
Wirth et al. 1996; Savarirayan and Bankier 1998; Wun-
derle et al. 1998); in 8 of these cases, the respective
translocation or inversion breakpoints have been
mapped to positions from 50 kb to possibly 350 kb
proximal to SOX9 (Foster et al. 1994; Wagner et al.
1994; Ninomiya et al. 1996;Wirth et al. 1996;Wunderle
et al. 1998). It has been argued that these translocations
or inversions either may act by exerting a long-range
position effect by removing one or more cis-regulatory
elements essential for correct SOX9 expression or, al-
ternatively, may disrupt a second CD gene (Foster et al.
1994; Wagner et al. 1994; Wirth et al. 1996). To shed
light on these alternatives and to define in greater detail
the critical region upstream of SOX9, we have more
precisely mapped the translocation breakpoints of three
CD cases described elsewhere (Wirth et al. 1996), and
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we also present clinical and mapping data for three novel
CD translocation cases. For this, we established a contig
of bacterial artificial chromosome (BAC) and P1 artifi-
cial chromosome (PAC) clones that incorporates a total
of 50 sequence-tagged site (STS) markers and spans
∼1,200 kb of DNA upstream of SOX9. We show that
translocations with breakpoints890–950 kb proximal
to SOX9 result in the CD phenotype. Extensive DNA
sequencing of this region fails to reveal clear evidence




Patient YS (case 8 in tables 1 and 2).—This male pro-
band was the second live-born child of a 28-year-old
mother and a 30-year-old father. The parents were phe-
notypically normal, as was the elder sister. The preg-
nancy was normal. The child was delivered at term, by
cesarean section, because of pathological cardiotoco-
gram. Birth weight was 3,540 g, length was 43 cm, and
head circumference was 38 cm. At birth, the boy dis-
played severe asphyxia and therefore needed intensive
care. He had dysmorphic features, which are summa-
rized in table 1. Moreover, the boy demonstrated the
following additional clinical signs: muscular hypotonia,
flat face, big eyes, nose with anteverted nostrils and ne-
vus flammeus on its tip, broad philtrum, high-arched
palate, dysmorphic ears with hypoplastic tragus, retrog-
nathia, short and narrow chest, decreased mobility of
the upper extremities, and pes adductus on the left side.
The iliac bones were dysplastic and wide apart. The
external genitalia were male with hypospadias. He did
not show either excessive skinfolds at the neck or os-
teoporosis. Because of the dysmorphic signs, chromo-
somal analysis was performed, which revealed, by GTG-
banding, a male karyotype with a balanced reciprocal
translocation of the long arms of chromosomes 10 and
17: 46,XY,t(10;17)(q24;q23). The karyotypes of the par-
ents were normal.
Patient MJ (case 9 in tables 1 and 2).—This female
proband was the second live-born child of 30-year-old
parents who were phenotypically normal, as was the
elder sister. Pregnancy was normal; only weak fetal
movements were reported. The child was delivered dur-
ing the 40th wk of gestation, by cesarean section, be-
cause of uterine insufficiency during the second stage of
labor. Birth weight was 3,930 g, length was 50 cm, head
circumference was 37 cm, and chest circumference was
30 cm. Physical examination revealed a hypotonic fe-
male infant with multiple dysmorphies, which are sum-
marized in table 1. In addition, the child displayed the
following clinical signs: muscular hypotonia, dolicho-
cephaly, short and down-slanting palpebral fissures,
small nose with upturned nostrils, long and wide phil-
trum, short neck with excessive skinfolds, and slight con-
tractures of elbow, hip, and knee joints. The external
genitalia were unambiguously female. During the first
months of life, the baby was hypotonic and required
tube feeding. Because of respiratory distress, supple-
mental oxygen by nasal cannula was indispensable.
Later, the girl developed growth retardation and was
unable to walk. Despite severe deficits in motor devel-
opment, her intellectual development was within normal
limits; she attends a regular public school. She is now
112 years of age.
Because of the multiple anomalies found, chromoso-
mal analysis was performed during the 3d wk of life and
revealed, by GTG-banding and FISH, a female karyo-
type with a balanced reciprocal translocation between
the long arms of chromosomes 5 and 17:
46,XX,t(5;17)(q13.3;q24.2). The karyotypes of the par-
ents were normal.
Patient MS (case 11, tables 1 and 2).—This male pro-
band was the second live-born child of a 28-year-old
mother and a 31-year-old father. The parents were un-
related and phenotypically normal, as was the elder sis-
ter. The family history was unremarkable. The preg-
nancy was normal. The child was delivered during the
38th wk of gestation, by cesarean section, because of
reduced fetal heart beats. Birth weight was 3,130 g,
length was 48 cm, and head circumference was 37.5 cm.
Perinatally, the boy displayed a severe asphyxia and
therefore needed nasal intubation. He had the dys-
morphic signs summarized in table 1. The child dem-
onstrated the following additional clinical features not
listed in table 1: generalized edema, flat face, small and
short nose with anteverted nostrils, long and flat phil-
trum, coarse-shaped ears, excessive skinfolds at the neck,
bell-shaped chest, short and clumsy hands, retarded
bone age, and osteoporosis. The external genitalia were
those of a normal male with a small penis. The boy
suffered from severe respiratory distress caused by trach-
eomalacia due to hypoplasia of the bronchial cartilage;
bilobectomy had to be performed at age 14 d, because
of infantile lobar emphysema of the upper and middle
lobe of the right lung. Malformations of other inner
organs were not demonstrable. Later, the boy developed
statomotor and psychomotor retardation. He died at age
6 years.
Chromosomal analysis was done on whole-blood cul-
tures during the neonatal period and was repeated when
the child was 2 years old. To obtain prometaphase chro-
mosomes, the cultures were treated with methotrexate
(0.05 mg/ml) after 48 h incubation; bromodeoxyuridine
(20 mg/ml) and fluorodeoxyuridine (1 mg/ml) were
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added 6 h before being harvested. RBA-, QFQ-,12
GTG-, and NOR-banding revealed a male karyotype
with a balanced reciprocal translocation between the
long arm of chromosome 17 and the short arm of chro-
mosome 22: 46,XY,t(17;22)(q25.1;p11.2). The karyo-
types of the parents were normal.
Somatic-Cell Hybridization
Human-mouse and human-hamster somatic-cell hy-
brids, with (a) either skin-fibroblast or lymphoblastoid
cell lines from patients with CD and (b) either mouse
RAG cells (Hprt) or hamster A3 cells (Tk), were es-
tablished as described elsewhere (Wagner et al. 1997).
Construction of BAC/PAC and Phage Contigs
To isolate BACs and PACs, a variety of probes—
including exon-trap fragments, STS markers generated
by Ge´ne´thon or the Whitehead Institute, and sequences
from an existing cosmid contig (Wirth et al.
1996)—were used to screen, by PCR, the human RPCI1
3-5 DNA Pools PAC library (provided by the German
Human Genome Project Resource Center, Berlin) and
the CITB Human BAC DNA Pools Release II (Research
Genetics). DNA from BAC and PAC clones was purified
by use of the Qiagen tip-100 kit, according to the man-
ufacturer’s protocols. Clones were end-sequenced by use
of T7 and Sp6 vector primers. New STS markers were
derived from single-copy sequences to rescreen the li-
braries for overlapping clones. PCR with these markers
was used on DNA from human-rodent somatic-cell hy-
brids containing one of the derivative chromosomes
from lymphoblastoid or fibroblast cell lines of CD trans-
location patients, to determine the orientation of sub-
contigs spanning the breakpoints in these hybrids.
To generate the phage contig, CEPH Mega-YAC
946E12 was first subcloned into lGET, a phage l-based
exon-trap vector that permits conversion of the phage
molecule into a multicopy plasmid by cre-lox-mediated
recombination (Nehls et al. 1994). The YAC was sub-
cloned, without prior purification from the yeast back-
ground, and recombinants with human inserts were se-
lected by plaque hybridization with radioactively labeled
human Cot-1 DNA (Gibco BRL). The plasmid versions
of 540 phages were gridded and dot-blotted onto nylon
filters. Two cosmids that had been shown to span several
translocation breakpoints in the 150–300-kb region 5′
to SOX9 were used as probes to isolate phage from the
YAC sublibrary. Inter-Alu PCR and vector-Alu PCR
(Lengauer et al. 1992), with these subclones as tem-
plates, were used to generate probes that were hybridized
back onto the sublibrary, to isolate overlapping clones.
BACs from the RPCI-11 library (BACPAC Resources,
Roswell Park Cancer Institute; Pieter de Jong, personal
communication) were isolated by hybridization to high-
density colony filters, by use of pools of overlapping
oligo probes (J. McPherson, personal communication).
Contigs based on marker content were generated by hy-
bridizing each clone identified during the library screen
with the individual markers. Paths of clones for sequenc-
ing were selected on the basis of marker content and
fingerprints (Marra et al. 1997).
PCR Typing of Microsatellite and STS Markers
Primer sequences used either already have been pub-
lished (D17S970, D17S1350, and GATA63G01
[GenBank]; and WI-5830, WI-2860, and WI-7760
[Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research]) or are available on request
from the authors (DP and RK markers). PCR reactions
were done in a total volume of 30 ml with either 10 ng
of BAC/PAC DNA or 200–400 ng of genomic DNA
from somatic-cell hybrids and with human and mouse
cells as controls, with 5 pmol of each primer in 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 1–1.5 mM MgCl2,
0.25% Nonidet P-40, 0.25 mg BSA/ml, 200 mM of each
dNTP, and 0.5 U of Taq polymerase.
Exon Trapping and Expression Analysis
Exon trapping was performed with the lGET vector
system, as described elsewhere (Nehls et al. 1994). The
same sublibrary of 540 lGET phage clones established
from YAC 946E12 for phage contig construction, as
outlined above, was used. The 540 phage clones were
subdivided into nine pools of 60 clones each, for elec-
troporation into COS-7 cells. The trapped fragments
from each individual pool were blunt-end cloned into
EcoRV-cut pBluescript KS vector (Stratagene) and were
sequenced from both strands, with vector primers.
For expression analysis of the trapped fragments, the
following cDNA libraries were screened: human fetal
brain (German Human Genome Project Resource Cen-
ter, Berlin), human amniocyte (a gift of H. Leffers, Den-
mark), mouse total embryo 9.5 dpc, and mouse adult
brain (German Human Genome Project Resource Cen-
ter, Berlin). For northern blot analysis, commercial mul-
tiple-tissue northern blots from Clontech were used.
FISH Analysis
BAC and PAC DNAs were labeled by nick translation
(Gibco BRL Nick translation kit) with 16-biotin-dUTP
(Boehringer Mannheim). Biotinylated probes were used
for chromosome in situ suppression hybridizations as
described by Toder et al. (1995). Biotinylated human
centromere-specific probes for chromosomes 10 and 17
were purchased fromOncor and were cohybridizedwith
the labeled BAC and PAC DNAs.
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Pulse-Field Gel Electrophoresis (PFGE) Analysis
The preparation of large DNA fragments from lym-
phoblastoid cell lines and from yeast was performed as
described by Scherer and Tsui (1991). Cell numberswere
adjusted such that lymphoblasts or6 72# 10 5# 10
yeast cells were present per agarose plug. Digestion of
genomic DNA in agarose plugs with rare-cutter restric-
tion enzymes was performed overnight in a volume of
300 ml with 6 U of enzyme/mg DNA.
For the sizing of BAC and PAC clones, the protocol
of Jones and Chi (in “DNA isolation in agarose plugs
for sizing and characterization of bacterial artificial
chromosome (BAC) clones” [BioMedNet, TechnicalTips
Online]) was used. One-fifth of a plug was digested over-
night with 50 U of NotI, to release the insert. After PFGE
and Southern blotting, filters were hybridized with ra-
dioactively labeled human Cot-1 DNA (Gibco BRL), to
evaluate the size of the human inserts.
High-molecular-weight DNA fragments were sepa-
rated by PFGE, as described elsewhere (Wirth et al.
1996). Yeast chromosomes (strain YP148) and phage-
lambda oligomers (Biorad Laboratories) were used as
size standards. A Waltzer-type electrophoresis unit was
used, with a switch-time between 20 s, for the sizing of
BACs and PACs, and 60 s, for the separation of digested
yeast and human genomic DNA. The 1.5 % FastLane
(FMC Bioproducts) agarose gel was run at 15C with a
field strength of 6 V/cm in run-0.5# Tris-acetate EDTA
ning buffer, for 24 h.
DNA Sequencing
Small-scale DNA sequencing of the various clone
DNAs was performed either with specific primers or
with vector primers. For the direct sequencing of BACs
and PACs, 2–3 mg of DNA were sequenced with vector
primers and fluorescent dye terminator technology
(BigDye Terminator Cycle Sequencing Ready Reaction
Kit; Perkin Elmer/Applied Biosystems), under the fol-
lowing PCR conditions: 97C for 5 min, followed by 35
cycles of 96C for 1 min, 50C for 1 min, and 60C for
4 min. The reactions were analyzed on ABI 373 or ABI
310 sequencers. Large-scale shotgun sequencing and as-
sembly of BACs and PACs was performed as described
elsewhere (Whitehead Institute for Biomedical Research/
MIT Center for Genome Research).
Computer-Assisted Sequence Analysis
The programs GENSCAN and GRAIL II (Grail) were
used to predict potential genes and exons in genomic
sequences. Alignments of predicted peptides against var-
ious databases were made by use of the NCBI’s BLAST
server (BLAST, National Center for Biotechnology In-
formation) and the programs BLASTP and TBLASTN.
Genomic sequences were also analyzed in blocks of 20
kb of sequence, by use of the BLASTN program against
the dbEST database and by use of the BLASTX program
against a nonredundant version of several protein
databases.
Results
Construction of a BAC/PAC Contig, Rare-Cutter Map,
and Sequence Analysis
To more precisely map the positions of three previ-
ously published CD translocation breakpoints (Wagner
et al. 1994; Wirth et al. 1996), as well as those of three
new cases, we set out to extend an existing cosmid contig
that ended 130 kb upstream of the SOX9 gene. First,
the nonchimeric YAC 946E12 of ∼2 Mb, spanning the
SOX9 gene and several CD translocation breakpoints
(Wirth et al. 1996), was subcloned into the phage-vector
lGET (Nehls et al. 1994). A total of 540 phage clones
from this sublibrary were then used to assemble a 120-
kb phage contig extending from STS marker DP 2 to
STS marker DP 8 and spanning three translocation
breakpoints (fig. 1A, not shown in detail).
As starting points for the construction of a BAC/PAC
contig, we used the markers DP 2 (fig. 1A, end of cosmid
contig as described by Wirth et al. [1996]), D17S970,
D17S1350, WI-7760, and the exon-trap fragment 38.14
(see the Exon Trapping subsection, below). Contig build-
ing was performed by end sequencing of newly identified
clones, to establish new STS markers for further rounds
of screening. The resulting contig (fig. 1A) extends as
much as ∼1,200 kb proximal to SOX9.
In parallel, we used all the STS markers as hybridi-
zation probes, to establish a long-range restriction map
on the basis of the YAC 946E12. Because YACs are
known to frequently delete variable parts of their inserts
(Nehls et al. 1995), we compared the restriction frag-
ments obtained with five different rare-cutter enzymes
after digestion of the YAC DNA versus those of genomic
DNA from several human lymphoblastoid cell lines,
probing with different markers from the contig. An SfiI
fragment of 940 kb in both YAC and lymphoblastoid-
cell DNA could be detected (fig. 2), suggesting that the
YAC faithfully represents the genomic sequence in the
contig region. (The SfiI site, which delimits the telomeric
end of this 940-kb fragment, is located 5 kb 5′ of the
SOX9 gene and was considered to be the 0-kb coordi-
nate in fig. 1B). Complete methylation of the CpG din-
ucleotides present in the recognition sites of BssHII,
MluI, and EagI was observed in DNA from lympho-
blastoid cells (not shown), whereas NruI showed partial
methylation of internal NruI sites, resulting in a 650-kb
fragment (Wirth et al. 1996). The corresponding sites
Figure 1 Map of 1.4-Mb region proximal to SOX9. A, BAC, PAC, cosmid, and phage contigs proximal to the SOX9 gene. The extent of the cosmid (Wirth et al. 1996) and phage contigs is
shown by a double arrow. BAC and PAC clones are drawn as horizontal lines (not to scale), with the clone identifiers given, on the right side, in regular print and italics, respectively. The insert sizes
of the clones are given in parentheses (in kb). Markers present on each clone are represented by circles, with blackened circles representing end sequence–derived STS markers used for subsequent
library screening. Note that PAC 283G12 has an internal deletion, as indicated by the dashed line. The order of all the markers present in the clone contig is shown above, with each circle representing
one marker. The exact order is not known for the markers SOX9 and WI-5830, given in parentheses. Clones with the prefix “hRPK or “hRPC” were chosen for sequencing and are indicated by the
thicker lines. The ends of sequence contigs are shown as blackened squares on the clone from which they derive and as unblackened squares on the clones on which they are present. Submitted
sequences from overlapping clones have been trimmed to a 2-kb overlap; the corresponding clones thus show two numbers in parentheses, the first referring to the insert size and the second referring
to the amount of sequence, in the database, derived from this clone. The GenBank accession numbers for the sequenced clones are AC005181 (hRPK.1003J3), AC005273 (hRPK.879D6), AC005138
(hRPK.261A13), AC005279 (hRPK.103M22), AC006473 (hRPK.203M16), AC006448 (hRPK.423M11), AC005144 (hRPK.465C12), and AC005152 (hRPC.1037O7). Ch chimeric end.B,Positions
of rare-cutter restriction-enzyme sites (drawn to scale). B  BssHII; E  EagI; M  MluI; N  NruI; S  SfiI. Sites present within a few kilobases, as in the SOX9 CpG island, are shown together,
with the frequency of occurrence of restriction-enzyme sites being represented by the numbers preceding the enzyme abbreviations. The accuracy of the position of the rare-cutter sites is estimated
to be within 10 kb for the sites not present in the sequenced regions, reflecting the resolution of PFGE. The direction of transcription of the 5.4-kb SOX9 gene is given by the outlined arrow. The
thicker lines represent the regions that have been completely sequenced. C, Position of translocation breakpoints. The circled numbers correspond to the case numbers shown in table 2, with the
zigzag arrows pointing to the middle of the interval where the breakpoints have been localized. The size of the interval as well as the karyotype of the cases is given in table 2. D, Position of trapped
exons, putative genes, and pseudogenes. “Ts.” denotes the cDNA described by Ninomiya et al. (1996), which was mapped 74–88 kb upstream of SOX9. “I”–“IV” denote positions of exon-trap
fragments: I  ET 38.9 (142 kb), II  ET 82.12 (172 kb), III  ET 82.14 (185 kb), and IV  ET 38.14 (686 kb); for details of the putative exons, see figure 4. The arrows above the trapped
fragments indicate the orientation of the flanking splice-donor and -acceptor sites. W-MYL6 is a MYL6 pseudogene published by Lenz et al. (1989) and located 457 kb centromeric to SOX9.
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Figure 2 PFGE analysis of YAC 946E12 and genomic controls.
Autoradiograph of a Southern blot from a pulse-field gel with SfiI-
digested DNA from YAC 946E12 and three lymphoblastoid cell lines
(controls 1–3), hybridized with a pool of STS fragments between DP
29 and SOX9 (fig. 1A). Note that the genomic 940-kb SfiI fragment
seen in the controls is also present in the YAC 946E12. LMZ limiting
mobility zone. The gel was run at 6 V/cm, switch time 60 s, for 24
h.
were all readily cut in the YAC DNA, because of the
lack of methylation in yeast.
The long-range map established from YAC 946E12
by use of the five rare-cutter enzymes used singly and in
combination is shown in figure 1B. The map extends
from a cluster of rare-cutter sites around the SOX9 gene
to ∼1,400 kb in the centromeric direction. In total, 50
STS markers are spread over a distance of 1,200 kb,
resulting in a mean marker density of 1 marker/24 kb.
All markers hybridized to fragments on the YAC rare-
cutter filters, providing further evidence for the integrity
of the YAC in the region studied.
The STS markers derived during contig building were
used to isolate additional BACs and PACs, to establish
an optimal path for genomic sequencing. The eight BACs
or PACs sequenced to date are indicated by thicker lines
in figure 1A, with squares denoting the centromeric or
telomeric ends of the individual sequence contigs. Spe-
cifically, the following regions, indicated by the thicker
black line in fig. 1B, have been completely sequenced:
88–285 kb, 332–995 kb, and 1,050–1,253 kb, all prox-
imal to SOX9. These 1,063 kb of sequence unequivo-
cally define the order of the STS markers and refine the
rare-cutter map established by PFGE.
Fine-Mapping of CD Translocation Breakpoints
In addition to the three CD translocation cases for
which we had previously mapped the breakpoints to
1130 kb upstream of SOX9 (Wirth et al. 1996; cases
5–7 in table 2), two new de novo translocation cases
(cases 8 and 9 in table 1; also see the Case Reports
subsection, above) with many features characteristic of
CD were made available to us. We also reanalyzed a
t(17;22) translocation case that we had published in the
context of generating a somatic cell–hybrid panel for
distal 17q but which, at the time, we had not recognized
as being a likely CD case (Wagner et al. 1997). After
additional, more-detailed clinical data were obtained, it
became apparent that this patient (case 11 in table 1;
also see the Case Reports subsection, above) had many
features typical of CD. We sequenced the SOX9 ORF,
as well as the four exon/intron junctions, in this and the
two new cases and did not find any mutation.
To locate the breakpoints in these six CD transloca-
tion cases, we isolated the derivative autosome of each
case from the der(17) and the normal chromosome 17,
in human/rodent somatic-cell hybrids. DNA from these
hybrids was then used for typing of STS markers from
our contig. Figure 1C shows the position of the various
breakpoints thus determined along the chromosome,
with the distances from SOX9 being listed in table 2.
As can be seen, the breakpoints of cases 5, 6, and 7
mapped, respectively, 134–142 kb (between RK 4 and
38.9), 173–179 kb (between RK 3 and DP 1), and
212–224 kb (between RK 1 and RK 6) centromeric to
SOX9. With positions at 228–229 kb (between DP 8
and DP 21) and 288–319 kb (between DP 13 and DP
22), the breakpoints of the two new cases, 8 and 9, are
also a considerable distance upstream of the SOX9 cod-
ing region. Remarkably, the breakpoint of case 11
mapped to the interval between DP 29 and DP 41a,
∼890–950 kb upstream of SOX9. DNA from the so-
matic-cell hybrid with the der(22) of this case typed pos-
itive for all STS markers from SOX9, up to and including
DP 29. The single exception was marker DP 21, which
was negative in PCR but was shown to be present by
Southern blot hybridization, which detected the same
fragment in both genomic DNA and in DNA from the
hybrid (not shown). The negative PCR result is therefore
most likely caused by a sequence polymorphism affect-
ing a primer-binding site.
FISH Analysis of CD Translocation Cases
The STS content mapping on the somatic-cell hybrids
showed that the breakpoints are scattered over a con-
siderable distance upstream of SOX9. To rule out the
presence of cloning artifacts during the preparation of
the hybrids, which could have resulted in erroneous PCR
results, we used BACs and PACs that were expected to
span the breakpoints as probes for FISH on metaphase
spreads from the patients’ cell lines. Figure 3 shows the
results for the three most distant cases—8, 9, and
Table 2
CD Translocation and Inversion Cases
Case Karyotype Sexa Campomeliab Survival Time
Distance to SOX9
(kb) Reference(s)
1 46,XY,t(7;17)(q34;q25.1) f* Severe 16 years 50 Tommerup et al. (1993); Wagner et al. (1994)
2 46,XY,t(12;17)(q21.32;q24.3-q25.1) f* None 11 mo 74–88c Ninomiya et al. (1995, 1996)
3 46,XY,t(2;17)(q35;q23-q24) f* Severe Abortion 88 Young et al. (1992); Foster et al. (1994)
4 46,XY,t(9;17) m Severe 13 years 110–140 Wunderle et al. (1998)
5 46,XY,t(13;17)(q22;q25.1) f* None 130 years 134–142c Tommerup et al. (1993); Wirth et al. (1996); present study
6 46,XX,t(1;17)(q42.13;q24.3-q25.1) f Severe 16 years 173–179c Tommerup et al. (1993); Wirth et al. (1996); present study
7 46,XY,t(6;17)(q14;q24) f* Mild 13 years 212–224c Wirth et al. (1996); present study
8 46,XY,t(10;17)(q24;q23) m Severe 11 year 228–229c Present study
9 46,XX,t(5;17)(q13.3;q24.2) f Severe 112 years 288–319c Present study
10 46,XY,inv(17)(q11.2;q24.3-q25.1) f* Mild 12 years 70–350 Mansour et al. (1995); Wunderle et al (1998)
11 46,XY,t(17;22)(q25.1;p11.2) m None 6 years 890–950c Wagner et al. (1997); present study
12 46,XX,inv(17)(q12;q25) f Severe 3 mo ? Maraia et al. (1991)
13 46,XX,t(4;17)(q21.3;q23.3) f Mild/none 12 years ? Mansour et al. (1995)
14 46,XX,t(5;17)(q15;q25.1) f Mild 11 d ? Savarirayan and Bankier (1998)
a f  XX female; f*  sex-reversed XY female; m  XY male.
b Severe  overt bending of long bones; Mild  only mild bowing of long bones; None  straight long bones.
c Accurate within 10 kb—for the absolute position of the interval relative to SOX9, not for the size of the interval itself (see legend to fig. 1B).
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Figure 3 FISH with BACs and PACs on metaphase spreads of
CD translocation cases. A, t(10;17) translocation (case 8; table 2) and
BAC 84P17 as probe (fig. 1A), showing overlapping hybridization
signals on der(10) and der (17). B, t(5;17) translocation (case 9; table
2) and PAC 297P01as probe (fig. 1A), showing overlapping signals on
der(5) and der(17). C, t(17;22) translocation (case 11; table 2) and
PAC 5P08 as probe (fig. 1A), showing overlapping signals on der(17)
and der(22). Centromere-specific probes for chromosomes 17 (A and
C) and 10 (A) were used. Centromeres of the chromosomes are in-
dicated by large arrowheads (A and C), and signals from the BAC and
PAC clones are indicated by small arrows.
11—with the clones 84P17 (fig. 3A), 297P01 (fig. 3B),
and 5P08 (fig. 3C), respectively. In all three cases, signals
could be seen on the normal chromosome 17, as well
as on the two derivative chromosomes, indicating that
all clones span the corresponding breakpoints on the
patients’ chromosomes. The same kind of analysis was
also done with CD translocation cases 5–7, with clones
from the 120-kb phage contig, again confirming the re-
sults from the somatic cell–hybrid analysis (data not
shown).
Analysis of Genomic Sequences
The 1,063 kb of genomic sequence established so far
(indicated by the thicker lines in fig. 1B) were searched
for potential genes and pseudogenes, by analysis of the
sequence by use of the GENSCAN gene-prediction pro-
gram (Burge and Karlin 1997) and by comparison of
the genomic sequence against the dbEST database by
use of the BLASTN program (Altschul et al. 1990). The
peptides predicted by GENSCAN were compared
against a nonredundant version of several protein da-
tabases, by the BLASTP program. In addition, we used
the TBLASTN program, to compare the peptides against
a six-frame translation of the dbEST database. Neither
strategy revealed any significant matches to known genes
in the 1,063 kb of sequence analyzed.
Mapping of Putative Genes and Pseudogenes
Of all translocation breakpoints mapped so far (table
2), only one has been shown to be in close proximity to
a gene or pseudogene. Ninomiya et al. (1996) isolated
a testis cDNA with a genomic fragment that contained
the breakpoint from a t(12;17) translocation case (case
2 in table 2). We mapped this transcript—and, conse-
quently, the breakpoint—to 74–88 kb proximal to
SOX9 (data not shown). The genomic sequence of this
potential gene is colinear with the published cDNA se-
quence, as determined by PCR with overlapping primer
pairs. This transcript could be derived from a pseudo-
gene, since it contains an Alu element at its 5′ end and
has no match to entries in the database, no introns, and
no obvious coding potential.
One of the markers used for contig building was
the EST-derived marker WI-7760, also known as
“D17S1993.” This marker, derived from the 3′ UTR of
the alkali myosin light-chain 6 gene (MYL6), has been
mapped to both chromosome 12 and chromosome 17,
by radiation-hybrid and STS content mapping (Genome
Database accession numbers 9767349, 1075901, and
9206886). Analysis of the genomic sequence locates this
marker to 457 kb proximal to SOX9, as part of a MYL6
pseudogene, a partial sequence of which has been de-
scribed elsewhere (Lenz et al. 1989).
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Figure 4 Exon fragments trapped from YAC 946E12. “I”–“IV”
denote the exon-trap fragments shown in figure 1D. Putative intron
sequences are given in lowercase, exon sequences in uppercase; the
invariant ag and gt nucleotides at the splice-acceptor and -donor sites,
respectively, are in boldface, as are the stop codons that close all read-
ing frames in ET 82.12, ET 38.14, and ET 38.15. The conceptual
translation of the ORFs from ET 38.9 and ET 82.14 is given below
the corresponding codons.
Exon Trapping
For exon trapping, we subcloned YAC 946E12 into
lGET, a phage vector designed for large-scale exon trap-
ping (Nehls et al. 1994). A total of 540 phages with a
mean insert length of 14 kb of human DNA were an-
alyzed, in nine pools. In addition, two pools of 20 clones
each, representing the phage contig shown in figure 1A,
were analyzed. Only five different fragments were re-
covered (see fig. 1D, I–IV; fragment V is located prox-
imal to the contig). Whereas this was not an exhaustive
analysis, because the redundancy of this sublibrary was
only approximately threefold, the small number of
trapped fragments is likely to reflect a low gene density
in this region.
Sequencing of the flanking regions of the exon-trap
fragments revealed canonical splice-donor and -acceptor
sites (see fig. 4). Only exon-trap fragments ET 38.9 and
ET 82.14 have an ORF, whereas ET 82.12, ET 38.14,
and ET 38.15 contain several stop codons that close all
three reading frames. By PCR, ET 38.15 was shown to
be present on YAC 946E12 and in DNA from a chro-
mosome 17–only hybrid (Wagner et al. 1997), but ab-
sent from the hybrids of the CD translocations, placing
it proximal to the contig shown in figure 1. Interestingly,
the fragments ET 38.9, ET 82.12, ET 82.14, and ET
38.14 (I-IV in fig. 1D) all have the same orientation
regarding their splice-donor and -acceptor sites, with
their inferred transcriptional orientation in the opposite
direction to that of the SOX9 gene.
The trapped fragments were hybridized as a pool to
cDNA libraries prepared from human fetal brain, human
amniocytes, mouse 9-day total embryo, and mouse adult
brain. No positive clones were detected. Northern blots
probed with the same pool of trapped fragments did not
reveal any signal in various human fetal and adult tis-
sues. Furthermore, database searches with the sequences
of the trapped fragments showed no matches to known
genes or transcripts, and none of the four trapped exons
I–IVwere predicted by either the GENSCANor theGrail
exon-prediction programs.
Discussion
Up to now, 14 CD cases with translocations or in-
versions involving distal 17q have been described, in-
cluding the three new cases from this study. Table 1
summarizes the clinical and radiological features of these
new cases. Patients number 8 and 9 show most of the
clinical manifestations typically seen in patients with CD
(Mansour et al. 1995). Both are still alive at 11 and 12
years of age, respectively (table 2). The third patient with
the t(17;22) translocation died at the age of 6 years. This
reflects the tendency of patients with CD translocation
to have a longer life expectancy than patients with mu-
tations in the SOX9 coding region (Mansour et al. 1995;
Wirth et al. 1996). Excluding the abortion case, 9 of the
13 patients with translocation or inversion survived for
12 years, and one patient (case 8) is just !2 years of age
(table 2). In contrast, only 1 of 28 patients with CD
without a chromosomal rearrangement survived 12
years (when terminated pregnancies are excluded), in a
study by Mansour et al. (1995). Likewise, of 22 patients
with CD with documented SOX9 coding-region muta-
tions and known survival status, only 5 survived 12
years (when terminated pregnancies are excluded) (Wag-
ner et al. 1994; Kwok et al. 1995; Cameron et al. 1996;
Meyer et al. 1997; Goji et al. 1998; Hageman et al.
1998). Three of these five long-term survivors had the
same Y440X stop-codon mutation (Wagner et al. 1994;
Meyer et al. 1997; Hageman et al. 1998), with the re-
sulting truncated SOX9 protein retaining some transac-
tivation potential (Meyer et al. 1997).
Another difference between the two classes of CDmu-
tations is the presence or absence of the eponymous fea-
ture, campomelia. In contrast to the 22 patients with
SOX9 ORF mutations who have been mentioned in the
preceding paragraph, only 1 of whom showed acam-
pomelic CD (Meyer et al. 1997), 7 of the 14 cases with
rearrangements outside the SOX9 gene show only mild
bowing or a complete lack of bending or bowing of the
upper or lower limbs (table 2). Likewise, in the study
by Mansour et al. (1995), only 2 of 36 cases showed no
or only mild campomelia, and these 2 (cases 10 and 13
in table 2) were patients with chromosomal rearrange-
ments outside the coding region.
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When the positions of the various breakpoints listed
in table 2 are compared, it is obvious that there is no
apparent correlation between the position of a break-
point and the phenotype of the patient. There are two
patients with breakpoints 110–142 kb upstream of
SOX9, one showing sex reversal and no bending of the
long bones (acampomelia; case 5) and the other pre-
senting with severe campomelia but without sex reversal
(case 4). Likewise, the survival time of the patients can-
not be correlated with the positions of the breakpoints,
since the patient with CDwho has the breakpoint closest
to SOX9 (case 1 in table 2) is still alive, whereas a patient
with a similar breakpoint (case 2 in table 2) died at age
11 mo. This lack of a genotype-phenotype correlation
parallels our previous results from the mutation analysis
of patients with CD with mutations in the coding region
of SOX9 (Meyer et al. 1997).
Table 2 summarizes our results and the data from the
literature regarding the distances of the various break-
points from the SOX9 gene. They all lie at considerable
distance proximal to SOX9, with the majority of the
cases having their breakpoints within an interval 50–350
kb upstream of the gene (also see fig. 1). The only ex-
ception is case 11, which has its breakpoint as far as
890–950 kb proximal to SOX9. This enormous distance
between a breakpoint and its corresponding gene is not
without precedent. de Kok et al. (1996) described a de-
letion hot-spot region 900 kb proximal to the POU3F4
gene in Xq21.1, where several deletions overlap in an
8-kb region in patients with X-linked deafness type 3
(DFN3). Several other examples, in human and mouse,
have been described in which chromosomal rearrange-
ments exert position effects on somewhat distant genes
(Bedell et al. 1996). For example, translocation break-
points have been mapped 85 kb 3′ to the PAX6 gene
in human aniridia (Fantes et al. 1995). Likewise, at the
murine Steel locus, chromosomal rearrangements in two
mutant alleles with breakpoints 115 kb and 195 kb
proximal to the Mgf gene have been shown to alter the
expression level of the Mgf gene (Bedell et al. 1995).
Different mutational mechanisms that could account
for the CD phenotype shown by the translocation cases
have been discussed elsewhere (Wirth et al. 1996). One
possibility is the disruption of alternative transcripts
from one or more upstream promotors. The existence
of a cartilage-specific and/or gonadal-specific promoter
still cannot be ruled out, because the SOX9 transcrip-
tional start site defined by us was found in fetal brain
tissue (Wagner et al. 1994). However, the fact that a
translocation breakpoint 1890 kb from SOX9 leads to
a CD phenotype would imply an intron of unprece-
dented length.
A second possibility is a classic position effect causing
altered SOX9 expression by translocating the gene into
a heterochromatic environment. The only case in which
such a mechanism could be operating is case 11, with
its breakpoint within band 22p11.2 (table 2), placing
the SOX9 gene rather close to the centromere and !1
Mb from a chromosomal region that is generally as-
sumed to consist of highly repetitive sequences.
Third, the breakpoints could disrupt a second CD-
causing gene on 17q. From the analysis of the 1,063 kb
of sequence available, it does not seem that the chro-
mosomal rearrangements seen in our cases disrupt any
protein-coding gene. In addition, we failed to detect ex-
pression of the fragments recovered by exon trapping,
nor did we find matches in the dbEST database. How-
ever, because SOX9 is also expressed early in develop-
ment, we may have missed the appropriate tissue and/
or time of expression. Interestingly, the four fragments
have the same putative transcriptional orientation and
could derive from the same noncoding transcriptional
unit. Noncoding RNAs such as the human XIST tran-
script have been described (Brown et al. 1992) that exert
their function at the level of the RNA molecule. The
transcript described by Ninomiya et al. (1996) is not
very likely to represent such a regulatory RNA, because,
in the majority of the CD translocation cases, it is not
separated from SOX9. Nevertheless, several transcrip-
tion units present in the region could act together to
open up the chromatin and to allow transcription of
SOX9. Such a mechanism has been proposed by Suth-
erland et al. (1996), who found noncoding transcripts
disrupted by a translocation event in a patient with
DiGeorge syndrome.
The fourth and most likely mutational mechanism is
the removal of one or more cis-regulatory elements from
an extended SOX9 control region. Support for this no-
tion comes from recent work by Wunderle et al. (1998),
which describes mice transgenic for truncated versions
of the human YAC 946E12 carrying a SOX9-lacZ fusion
gene. Comparing the expression of the SOX9-lacZ gene
versus endogenous Sox9, they observed highly similar
expression patterns during skeletal development when
the transgenic YAC contained 350 kb of SOX9 upstream
sequence but a drastic reduction of expression in all
tissues except the neuroectoderm when the transgenic
YAC contained only 75 kb of SOX9 5′-flanking se-
quence. Neither YAC transgene showed expression in
the developing gonads. These data strongly argue for the
presence of multiple cis-acting elements scattered over a
region 350 kb upstream of SOX9. Given the incom-
plete expression pattern of the larger construct, one has
to assume either species-specific elements not working
in the mouse or the presence of additional elements 1350
kb from SOX9. Such additional regulatory elements
could perhaps be 1890 kb from SOX9, as indicated by
the t(17;22) breakpoint, unless we invoke the hetero-
chromatin effect discussed above. In this context, it must
be stressed that, although extensive STS content map-
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ping and PFGE analysis of the isolated der(22) chro-
mosome provided no evidence that a deletion between
the breakpoint and SOX9 may have occurred concom-
itantly with the translocation, a small deletion or an
inversion cannot entirely be ruled out by these data. This
caveat also applies to the other translocation cases.
The assumption that the translocations disrupt cis-
acting regulation of SOX9 implies an altered expression
of the SOX9 allele on the translocation chromosome.
By exploiting a SOX9 coding region–sequence poly-
morphism, we have had previously found (and reported
elsewhere [Wirth et al. 1996]) a similar expression level
for both SOX9 alleles in the t(13;17) translocation case.
This result, however, was obtained from a low-expres-
sion lymphoblastoid cell line and thus may reflect basal
promoter activity rather than the regulated expression
of SOX9 during embryonic development (Wright et al.
1995). SOX9 expression in embryonic tissue from CD
translocation cases could not be analyzed, since such
tissue was not available to us.
The most accurate cytogenetic measurements place the
CD translocation breakpoints at the border between the
G band, at 17q24.3, and the R band, at 17q25.1 (Tom-
merup et al. 1993). G bands are known to be generally
AT rich and gene poor, whereas R bands have a higher
GC content and a higher gene density (Bernardi 1995).
We note that the GC content of the three sequence con-
tigs in the 1.3-Mb region 5′ to SOX9 (thicker lines in
fig. 1B) slightly increases from the centromeric side: from
37.5% to 37.7% to 40.3%, finally reaching 52.0% in
an 8-kb-sequence contig that includes the 5.4-kb SOX9
gene (G.S., unpublished data). The present data indicate
that, on the basis of its GC content, the region 5′ to
SOX9 belongs to the GC-poor isochores of the L1 and
L2 families that are mainly present in G bands but also
in R bands, whereas the SOX9 gene and surrounding
sequences belong to the GC-rich H2 isochore found ex-
clusively in R bands (Bernardi 1995). The picture thus
emerging from the cytogenetic and sequence data is that
SOX9 may in fact be located at the transition zone be-
tween a G band and an R band. This makes it partly
understandable why the region centromeric to SOX9 is
devoid of protein-coding genes—and why a small gene
such as SOX9 may have the luxury of distributing its
regulatory elements over such an enormous distance.
Interestingly, our recent data show that the 5′-flanking
region of the SOX9 orthologue in the pufferfish Fugu
rubripes extends over ∼65 kb (Pfeifer et al. 1998), an
unusually large intergenic region for the otherwise com-
pact Fugu genome. This observation could indicate the
need for an extended SOX9 control region in vertebrates
in general. Once the sequencing of both the region prox-
imal to SOX9 in the human and the corresponding re-
gion in the mouse, a project that is now under way, is
completed, we will be able to compare these sequences
versus the more distantly related Fugu sequence, to iden-
tify conserved elements that can subsequently be tested
in transgenic mouse experiments, for their potential to
drive the expression of a reporter gene toward the right
tissue and time point during development.
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